Active ingredientBenperidolCat. No. P-B034-001CAS 2062-84-2Family · Pharmaceutical analytical standards
Benperidol
An antipsychotic of the butyrophenone family, the same as haloperidol, discovered in Belgium in 1961 and on the market since the mid-1960s: its uses include the treatment of schizophrenia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is a very high-potency neuroleptic: dose for dose it is about one and a half to two times as strong as its close relative haloperidol.
Go to the active ingredient →Active ingredientBenperidolCat. No. P-B034-001CAS 2062-84-2
Pharmacopoeial impurityBenperidol EP Impurity ACat. No. P-B034-002CAS 20662-53-7
Isotopically labelledBenperidol-d4Cat. No. P-B034-003
NitrosamineN-Nitroso BenperidolCat. No. P-B034-004
Impurity4-Chloro-4'-fluorobutyrophenoneCat. No. P-B034-005CAS 3874-54-2
Impuritytrans-Benperidol N-OxideCat. No. P-B034-006CAS 118435-01-1No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceBenperidol CRSEDQM code B0470000Family BenperidolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.